Scientific and regulatory aspects of nutraceutical products in the United States

Drug Development and Industrial Pharmacy

Volumn 24, Issue 12, 1998, Pages 1177-1195

  Kottke, M K ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; HERBACEOUS AGENT; MINERAL; VITAMIN;

DIET SUPPLEMENTATION; DRUG INDUSTRY; DRUG LABELING; DRUG LEGISLATION; FOOD INDUSTRY; HEALTH FOOD; NUTRIENT; REVIEW; UNITED STATES;

EID: 0031730282     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049809108576     Document Type: Review

References (58)

1. M. R. Vogel, Natural products issue, Pharm. Today, 4(2), 14-24 (1998).
2. V. E. Tyler and F. Foster, Herbs and phytochemicals, in Handbook of Nonprescription Drugs (T. R. Covington, R. R. Berardi, L. L. Young, S. C. Kendall, and M. J. Hickey, eds.), American Pharmaceutical Association, Washington, DC, 1996, pp. 695-713.
3. S. L. DeFelice, The Nutraceutical Initiative: A Proposal for Economic and Regulatory Reform, 1991.
4. Food Focus, Toronto, Ontario, Nutraceuticals/functional foods: An exploratory survey on Canada's potential: Summary report, J. Nutr. Func. Med. Foods, 1(1), 83-99 (1997).
5. A. Bloch and C. A. Thomson, Position of the American Dietetic Association: Phytochemicals and functional foods, J. Nutr. Func. Med. Foods, 1(1), 33-45 (1997).
6. B. Evers and A. Mason, Functional foods: Opening the door to better health, Elec. Food Rap., 6(16) (1996).
7. C. Marcus and A. M. Coulston, The vitamins, in Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. (J. G. Hardman and L. E. Limbird, eds.), McGraw-Hill, New York, 1996, pp. 1547-1590.
8. F. C. Lowe and J. C. Ku, Phytotherapy in treatment of benign prostatic hyperplasia: A critical review, Urology, 43(1), 12-20 (1996).
9. S. Mobarhan, Micronutrient supplementation trials and the reduction of cancer and cerebrovascular incidence and mortality, Nutr. Rev., 52(3), 102-105 (1994).
10. C. A. Monteleone and A. R. Sherman, Nutrition and asthma, Arch. Intern. Med., 157, 23-34 (1997).
11. M. C. de Rijk, M. M. B. Breteler, J. H. den Breeijen, et al., Dietary antioxidants and Parkinson disease, Arch. Neurol., 54, 762-765 (1997).
12. D. B. Agus, S. S. Gambhir, W. M. Pardridge, et al., Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters, J. Clin. Invest., 100(11), 2842-2848 (1997).
13. I. Jialal and C. J. Fuller, Effect of Vitamin E, Vitamin C and beta-carotene on LDL oxidation and atherosclerosis, Can. J. Cardiol., 11(Suppl. G), 97G-103G (1995).
14. Food and Drug Administration, Rules and regulations, food labeling; nutrient content claims: Definition for "high potency" and definition of "antioxidant" for use in nutrient content claims for dietary supplements and conventional foods, Fed. Register, 62(184), 49868-49881 (1997).
15. P. G. Burney, G. W. Comstock, and J. S. Morris, Serologic precursors of cancer: Serum micronutrients and the subsequent risk of pancreatic cancer, Am. J. Clin. Nutr., 49(5), 895-900 (1989).
16. P. Mathew, R. Wyllie, F. Van Lente, R. M. Steffen, and M. H. Kay, Antioxidants in hereditary pancreatitis, Am. J. Gastroenterol., 91(8), 1558-1562 (1996).
17. L. C. Clark, G. F. Combs, B. W. Turnbull, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin, JAMA, 276, 1957-1963 (1996).
18. A. B. Nelson, B. H. S. Lau, N. Ide, and Y. Rong, Pycnogenol inhibits macrophage oxidative burst, lipoprotein oxidation, and hydroxyl radical-induced DNA damage, Drug Dev. Ind. Pharm., 24(2), 139-144 (1998).
19. C. H. Hennekens, J. E. Buring, J. E. Manson, et al., Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease, N. Engl. J. Med., 334(18), 1145-1149 (1996).
20. G. S. Omenn, G. E. Goodman, M. D. Thornquist, J. Balmes, et al., Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease, N. Engl. J. Med., 334(18), 1150-1155 (1996).
21. D. F. Birt, A. D. Julius, C. E. Runice, L. T. White, T. Lawson, and P. M. Pour, Enhancement of BOP-induced pancreatic carcinogenesis in selenium-fed Syrian golden hamsters under specific dietary conditions, Nutr. Cancer, 11(1), 21-33 (1988).
22. J. Braeckman, The extract of Serenoa repens in the treatment of benign prostatic hyperplasia: A multicenter open study, Curr. Ther. Res., 55(7), 776-785 (1994).
23. D. Wheatley, LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients - A controlled 6-week clinical trial, Pharmacopsychiatry, 30(Suppl. 2), 77-80 (1997).
24. S. Kasper, Treatment of seasonal affective disorder (SAD) with hypericum extract, Pharmacopsychiatry, 30(Suppl. 2), 89-93 (1997).
25. K. Linde, G. Ramirez, C. D. Mulrow, A. Pauls, W. Weidenhammer, and D. Melchart, St. John's wort for depression - An overview and meta-analysis of randomised clinical trials, BMJ, 313(7052), 253-258 (1996).
26. H. Wagner and S. Bladt, Pharmaceutical quality of hypericum extracts, J. Geriatr. Psychiatry Neurol., 7(Suppl. 1), S65-S68 (1994).
27. D. Melchart, K. Linde, F. Worku, L. Sarkady, M. Holzmann, K. Jurcic, and H. Wagner, Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea, J. Alt. Complement. Med., 1(2), 145-160 (1995)
28. R. J. Mullins, Echinacea-associated anaphylaxis, Med. J. Aust., 168(4), 170-171 (1998).
29. Food and Drug Administration, Proposed rule, dietary supplements containing ephedrine alkaloids, Fed. Register, 62(107), 30677-30724 (1997).
30. M. J. Wargovich, Experimental evidence for cancer preventative elements in foods. Cancer Lett., 114, 11-17 (1997).
31. J. Salmerón, J. E. Manson, M. J. Stampfer, et al., Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women, JAMA, 277, 472-477 (1997).
32. J. Slavin, D. Jacobs, and L. Marquat, Whole-grain consumption and chronic disease: Protective mechanisms, Nutr. Cancer, 27(1), 14-21 (1997).
33. R. Chang, Functional properties of edible mushrooms, Nutr. Rev., 54(11), S91-S93 (1996).
34. D. A. McCarron, S. Oparil, A. Chait, et al., Nutritional management of cardiovascular risk factors. Arch. Intern. Med., 157, 169-177 (1997).
35. D. P. Chapman and W. H. Giles, Pharmacologic and dietary therapies in epilepsy: Conventional treatments and recent advances, South. Med. J., 90(5), 471-480 (1997).
36. R. Sayegh, I. Schiff, J. Wurtman, P. Spiers, J. McDermott, and R. Wurtman, The effect of a carbohydrate-rich beverage on mood, appetite and cognitive function in women with premenstrual syndrome, Obstet. Gynecol., 86(4, Pt. 1), 520-528 (1995).
37. J. J. Wurtman, A. Brzezinski, R. J. Wurtman, and B. Laferrere, Effect of nutrient intake on premenstrual depression. Am. J. Obstet. Gynecol., 161(5), 1228-1234 (1989).
38. J. J. Wurtman, Depression and weight gain: The serotonin connection, J. Affect. Disord. 29(2-3), 183-192 (1993).
39. F. R. Kaufman, M. Halvorson, and N. D. Kaufman, A randomized, blinded trial of uncooked cornstarch to diminish nocturnal hypoglycemia at Diabetes Camp, Diabetes Res. Clin. Pract., 30, 205-209 (1995).
40. F. R. Kaufman, Zbar as part of the diabetes regimen, Clin. Res. Reg. Aff., 14(1), 75-82 (1997).
41. G. Alton, S. Kjaergaard, J. R. Etchison, F. Skovby, and H. H. Freeze, Oral ingestion of mannose elevates blood mannose levels: A first step toward a potential therapy for carbohydrate-deficient glycoprotein syndrome Type I, Biochem. Mol. Med., 60, 127-133 (1997).
42. N. R. M. Buist, A. P. Prince, K. L. Huntington, J. M. Tuerck, and D. D. Waggoner, A new amino acid mixture permits new approaches to the treatment of phenylketonuria, Acta Paediatr., Suppl. 407, 75-77 (1994).
43. Food and Drug Administration, Advance Notice of Proposed Rulemaking, eligibility criteria for considering additional conditions in the Over-the-Counter Drug Monograph System; request for information and comments, Fed. Register, 61(193), 51625-51631 (1996).
44. Food and Drug Administration, Final Rule, food labeling regulation, amendments; food regulation uniform compliance date; and new dietary ingredient premarket notification, Fed. Register, 62(184), 49825-49858 (1997).
45. Food and Drug Administration, Final Rule, food labeling; requirements for nutrient content claims, health claims, and statements of nutritional support for dietary supplements. Fed. Register, 62(184), 49859-49868 (1997).
46. Food and Drug Administration, Final Rule, food labeling; notification procedures for statements on dietary supplements, Fed. Register, 62(184), 49883-49886 (1997).
47. Food and Drug Administration, Final Rule, premarket notification for a new dietary ingredient. Fed. Register, 62(184), 49868-49881 (1997).
48. J. Strobos, Medical foods. Clin. Res. Reg. Aff., 14(1), 5-13 (1997).
49. Food and Drug Administration, Advance Notice ot Proposed Rulemaking, regulation of medical foods. Fed. Register, 61(231), 60661-60671 (1996).
50. Food and Drug Administration, Proposed Rule, regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body, Fed. Register, 63(82), 23623-23632 (1998).
51. Food and Drug Administration, Comments on Report of the Commission on Dietary Supplement Labels, Fed. Register, 63(82), 23633-23637 (1998).
52. L. V. Allen, Jr., Nutritional products, in Handbook of Nonprescription Drugs (T. R. Covington, R. R. Berardi, L. L. Young, S. C. Kendall, and M. J. Hickey, eds.), American Pharmaceutical Association, Washington, DC, 1997, pp. 361-392.
53. K. Sharp and B. Chi-Lum, Nutritional basics, Health Insight, posted May 30, 1997.
54. J. A. Duke, The Green Pharmacy, Rodale Press, Emmaus, PA, 1997.
55. Food and Drug Administration, Center for Food Safety and Applied Nutrition, A Food Labeling Guide, September 1994; updated May 1997.
56. L. C. Knodel, S. C. Kendall, L. L. Young, and M. J. Hickey, Nonprescription Products: Formulations and Features '96-97, American Pharmaceutical Association, Washington, DC, 1997, pp. 263-270, 276-281.
57. E. A. Martin and B. Guidos (eds.), The Bantam Medical Dictionary, rev. ed., Bantam Books, New York, 1990.
58. C. Mueller and M. Nestle, Regulation of medical foods: Toward a rational policy, NCP, 10(1), 8-15 (1995).